Anzeige
Mehr »
Mittwoch, 29.10.2025 - Börsentäglich über 12.000 News
Die 80-Milliarden-Dollar-Nuklear-Renaissance: Warum Uran der heißeste Sektor der Welt ist
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

WKN: A0MS6X | ISIN: US6024961012 | Ticker-Symbol: N/A
NASDAQ
29.10.25 | 20:59
7,190 US-Dollar
+4,51 % +0,310
1-Jahres-Chart
MIMEDX GROUP INC Chart 1 Jahr
5-Tage-Chart
MIMEDX GROUP INC 5-Tage-Chart

Aktuelle News zur MIMEDX Aktie

Aktienalarm. Jetzt kostenlos anmelden!

E-Mail
Aktivieren
  • Alle
  • Pressemitteilungen
  • Empfehlungen
  • Chartanalysen
  • Berichte
ZeitAktuelle Nachrichten
Sprache: Alle DE EN
LeserMedien
MIMEDX Aktie jetzt für 0€ handeln
21:48MiMedx Group Non-GAAP EPS of $0.15 beats by $0.08, revenue of $113.7M beats by $18.97M1
21:29MiMedx Group Inc. Profit Advances In Q32
21:07MIMEDX GROUP, INC. - 8-K, Current Report1
21:06MiMedx Group, Inc: MIMEDX Announces Record Revenue for Third Quarter 20251
21:01MIMEDX GROUP, INC. - 10-Q, Quarterly Report1
06.10.MiMedx Group, Inc: MIMEDX Announces Launch of EPIXPRESS2
03.09.MiMedx auf der Cantor Global Healthcare Konferenz: Wachstumsstrategie und optimistischer Ausblick3
03.09.MIMEDX GROUP, INC. - 8-K, Current Report2
31.07.MiMedx stock price target raised to $12 from $11 at Cantor Fitzgerald3
31.07.MiMedx raises full-year revenue growth outlook to low double digits as momentum builds post-record quarter5
31.07.MiMedx Partners With Vaporox To Expand Wound Care Portfolio And Invests In VHT Technology1
30.07.MiMedx Group, Inc: MIMEDX Announces Record Second Quarter 2025 Operating and Financial Results212Highest Quarterly Net Sales in MIMEDX History Second Quarter Net Sales of $99 million Grew 13% Year-Over-Year Second Quarter GAAP Net Income and Diluted Earnings Per Share were $10 Million and $0.06...
► Artikel lesen
30.07.MiMedx partners with Vaporox to co-market wound care products1
30.07.MiMedx Group, Inc: MIMEDX Announces Strategic Collaboration with Vaporox, Inc.169MARIETTA, Ga., July 30, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") and Vaporox, Inc. ("Vaporox") today jointly announced a collaboration, whereby the companies...
► Artikel lesen
29.07.SA analyst upgrades/downgrades: OXY, AMZN, MDXG, CHTR40
28.07.MIMEDX GROUP, INC. - S-8, Securities to be offered to employees in employee benefit plans2
15.07.MiMedx Group, Inc: MIMEDX Comments on Proposed Medicare Reimbursement Rule Changes for CY 2026249MARIETTA, Ga., July 15, 2025 (GLOBE NEWSWIRE) -- MiMedx Group, Inc. (Nasdaq: MDXG) ("MIMEDX" or the "Company") today commented on the Centers for Medicare and Medicaid Services ("CMS") release of...
► Artikel lesen
15.07.Cantor Fitzgerald reiterates Overweight rating on MiMedx stock amid CMS reimbursement changes2
14.07.MiMedx and Organogenesis stocks tumble after CMS proposal to slash spending3
24.06.Positive Signal: James L Bierman Shows Faith, Buying $185K In MiMedx Group Stock3
Weiter >>
33 Nachrichten in den letzten 12 Monaten
Ich würde die Aktie auf Sicht von 6 Monaten
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
1,1,1